HK1058762A1 - Carbamate compounds for use in preventing or treating bipolar disorder - Google Patents

Carbamate compounds for use in preventing or treating bipolar disorder

Info

Publication number
HK1058762A1
HK1058762A1 HK04101490A HK04101490A HK1058762A1 HK 1058762 A1 HK1058762 A1 HK 1058762A1 HK 04101490 A HK04101490 A HK 04101490A HK 04101490 A HK04101490 A HK 04101490A HK 1058762 A1 HK1058762 A1 HK 1058762A1
Authority
HK
Hong Kong
Prior art keywords
sub
preventing
bipolar disorder
phenyl
alkyl
Prior art date
Application number
HK04101490A
Other languages
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HK1058762A1 publication Critical patent/HK1058762A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK04101490A 2001-02-27 2004-03-01 Carbamate compounds for use in preventing or treating bipolar disorder HK1058762A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005425 WO2002067924A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
HK1058762A1 true HK1058762A1 (en) 2004-06-04

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101490A HK1058762A1 (en) 2001-02-27 2004-03-01 Carbamate compounds for use in preventing or treating bipolar disorder

Country Status (26)

Country Link
US (1) US7122576B2 (zh)
EP (1) EP1368021B1 (zh)
JP (1) JP4276839B2 (zh)
KR (1) KR20030074849A (zh)
CN (1) CN1250214C (zh)
AT (1) ATE378046T1 (zh)
AU (1) AU2002242226B2 (zh)
BR (1) BR0207832A (zh)
CA (1) CA2439292A1 (zh)
CY (1) CY1107199T1 (zh)
CZ (1) CZ296641B6 (zh)
DE (1) DE60223506T2 (zh)
DK (1) DK1368021T3 (zh)
ES (1) ES2295320T3 (zh)
HK (1) HK1058762A1 (zh)
HU (1) HUP0303261A3 (zh)
IL (2) IL157589A0 (zh)
MX (1) MXPA03007716A (zh)
MY (1) MY133370A (zh)
NO (1) NO20033799L (zh)
NZ (1) NZ527989A (zh)
PL (1) PL364640A1 (zh)
PT (1) PT1368021E (zh)
RS (1) RS50680B (zh)
RU (1) RU2286147C2 (zh)
WO (1) WO2002067924A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515374A (pt) * 2004-09-16 2008-07-22 Janssen Pharmaceutica Nv métodos de tratamento de epileptogenêse e epilepsia
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0520451A2 (pt) * 2005-07-26 2009-05-12 Janssen Pharmaceutica Nv métodos para tratamento de distúrbios associados a substáncias quìmicas
MX2009004770A (es) * 2006-10-30 2009-08-17 Janssen Pharmaceutica Nv Compuestos de carbamato para usarse en el tratamiento de la depresion.
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
WO2009104739A1 (ja) * 2008-02-21 2009-08-27 田辺三菱製薬株式会社 経口投与用固形製剤
EP2317852B1 (en) 2008-07-16 2014-12-24 Richter Gedeon Nyrt. Pharmaceutical formulations containing dopamine receptor ligands
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
MX2019006940A (es) * 2016-12-14 2019-09-06 Sk Biopharmaceuticals Co Ltd Uso de compuestos de carbamato para prevencion, alivio o tratamiento del trastorno bipolar.
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
ATE378046T1 (de) 2007-11-15
EP1368021B1 (en) 2007-11-14
PL364640A1 (en) 2004-12-13
RU2286147C2 (ru) 2006-10-27
PT1368021E (pt) 2007-12-19
RS50680B (sr) 2010-06-30
BR0207832A (pt) 2004-06-22
JP4276839B2 (ja) 2009-06-10
CN1503666A (zh) 2004-06-09
JP2004525905A (ja) 2004-08-26
YU68003A (sh) 2006-08-17
DE60223506D1 (de) 2007-12-27
IL157589A (en) 2009-09-22
IL157589A0 (en) 2004-03-28
WO2002067924A1 (en) 2002-09-06
AU2002242226B2 (en) 2006-06-29
DE60223506T2 (de) 2008-09-18
DK1368021T3 (da) 2008-02-11
CZ296641B6 (cs) 2006-05-17
CN1250214C (zh) 2006-04-12
MY133370A (en) 2007-11-30
NZ527989A (en) 2005-12-23
HUP0303261A2 (hu) 2004-01-28
CZ20032312A3 (cs) 2004-06-16
EP1368021A1 (en) 2003-12-10
NO20033799L (no) 2003-09-10
MXPA03007716A (es) 2004-11-12
HUP0303261A3 (en) 2012-07-30
NO20033799D0 (no) 2003-08-26
KR20030074849A (ko) 2003-09-19
ES2295320T3 (es) 2008-04-16
CY1107199T1 (el) 2012-11-21
US20020193433A1 (en) 2002-12-19
RU2003128996A (ru) 2005-03-10
CA2439292A1 (en) 2002-09-06
US7122576B2 (en) 2006-10-17

Similar Documents

Publication Publication Date Title
IL157589A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
MY157373A (en) Carbamate compounds for use in preventing or treating movement disorders
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
HK1063436A1 (en) Carbamate compounds for use in preventing or trea ting bipolar disorder
HK1062270A1 (en) Carbamate compounds for use in preventing or treating anxiety disorders
MY127317A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
HK1063288A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2003007934A8 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130221